Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study

<p><strong>Objectives:</strong><br /> Concern has been raised in the rheumatology community regarding recent regulatory warnings that HCQ used in the coronavirus disease 2019 pandemic could cause acute psychiatric events. We aimed to study whether there is risk of incident de...

Full description

Bibliographic Details
Main Authors:	Lane, JCE, Weaver, J, Kostka, K, Duarte-Salles, T, Abrahao, MTF, Alghoul, H, Alser, O, Alshammari, TM, Areia, C, Biedermann, P, Banda, JM, Burn, E, Casajust, P, Fišer, K, Hardin, J, Hester, L, Hripcsak, G, Kaas-Hansen, BS, Khosla, S, Kolovos, S, Lynch, KE, Makadia, R, Mehta, PP, Morales, DR, Morgan-Stewart, H, Mosseveld, M, Newby, D, Nyberg, F, Ostropolets, A, Park, RW, Prats-Uribe, A, Rao, GA, Reich, C, Rijnbeek, P, Sena, AG, Shoaibi, A, Spotnitz, M, Subbian, V, Suchard, MA, Vizcaya, D, Wen, H, Wilde, MD, Xie, J, You, SC, Zhang, L, Lovestone, S, Ryan, P, Prieto Alhambra, D
Other Authors:	OHDSI-COVID-19 consortium
Format:	Journal article
Language:	English
Published:	Oxford University Press 2020

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study

Similar Items